Organic sodium salts
Medchemexpress LLC NBQX | 118876-58-7 | C12H8N4O6S | 25 MG
NBQX (FG9202) is a highly selective and competitive AMPA receptor antagonist with neuroprotective and anticonvulsant activity.
- High affinity for AMPA and kainate binding sites.
- Minimal or no affinity for the glutamate recognition site on the NMDA receptor complex.
- Effective in decreasing seizures induced by PTZ.
- Neuroprotective in a focal ischaemia model.
Medchemexpress LLC NBQX | 118876-58-7 | C12H8N4O6S | 50 MG
NBQX (FG9202) is a highly selective and competitive antagonist of the AMPA receptor, exhibiting both neuroprotective and anticonvulsant properties.
- Acts as a highly selective and competitive AMPA receptor antagonist.
- Possesses neuroprotective activity.
- Demonstrates anticonvulsant activity.
- Shows high affinity for AMPA and kainate binding sites.
- Exhibits minimal or no affinity for the glutamate recognition site within the NMDA receptor complex.
![eMolecules 1907-33-1 | Lithium tert-butoxide | Chem-Impex | MFCD00050479 | 80.060 | C4H9LiO | 99.000 | [Li+].CC(C)(C)[O-] | 100g | 809117724](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000162430.jpg-250.jpg)
eMolecules 1907-33-1 | Lithium tert-butoxide | Chem-Impex | MFCD00050479 | 80.060 | C4H9LiO | 99.000 | [Li+].CC(C)(C)[O-] | 100g | 809117724
Lithium tert-butoxide | Chem-Impex | 1907-33-1 | MFCD00050479 | 80.060 | C4H9LiO | 99.000 | [Li+].CC(C)(C)[O-] | 100g | 809117724
Medchemexpress LLC Benzo[f]quinoxaline-7-sulfonamide, 1,2,3,4-tetrahydro-6-nitro-2,3-dioxo- | 118876-58-7 | C12H8N4O6S | 100 MG
NBQX is a highly selective and competitive AMPA receptor antagonist with demonstrated neuroprotective and anticonvulsant activity.
- Highly selective and competitive AMPA receptor antagonist.
- Exhibits high affinity for AMPA and kainate binding sites.
- Minimal or no affinity for the glutamate recognition site on the NMDA receptor complex.
- Decreases seizures induced by PTZ.
- Neuroprotective in a focal ischaemia model.
Medchemexpress LLC UDP-glucuronic acid trisodium | 63700-19-6 | 100 MG
UDP-glucuronic acid trisodium (Uridine 5'-diphosphoglucuronic acid trisodium salt) is a crucial precursor for vital glycoconjugates found across biological kingdoms, including mammalian glycosaminoglycans, plant cell wall polysaccharides, and bacterial capsule glycoglycerolipids. It is intended for research use only.
- Promotes migration of liver cancer cells (Huh7, SK-Hep1, SNU449) by inducing EMT process.
- Molecular Formula: C15H19N2Na3O18P2.
- Molecular Weight: 646.23.
- Target: Drug intermediate.
- Soluble in H2O (≥ 100 mg/mL) and DMSO (20 mg/mL).
- Store solid at -20°C; store in solvent at -80°C for 6 months or -20°C for 1 month.
Apexbio Technology LLC CNQX disodium salt 479347-85-8 10mg
CNQX disodium salt (CAS 479347-85-8) is a competitive antagonist of non-NMDA glutamate receptors specifically targeting AMPA and kainate subtypes with IC50 values of 0 3 M and 1 5 M respectively By inhibiting these receptors CNQX blocks fast excitatory synaptic transmission in the central nervous system In thalamic reticular neurons CNQX induces sustained depolarization while showing minimal effect on ventrobasal neurons In vivo administration of CNQX in rats reduces capsaicin-induced c-fos expression in the trigeminal nucleus caudalis without influencing other reticular regions CNQX is widely used to delineate non-NMDA receptor functions in neurophysiological and behavioral studies
Medchemexpress LLC CNQX | 115066-14-3 | C9H4N4O4 | 1 ML
CNQX (FG9065) is a potent and competitive AMPA/kainate receptor antagonist with IC50s of 0.3 μM and 1.5 μM, respectively. It is also a competitive non-NMDA receptor antagonist, capable of blocking the expression of fear-potentiated startle in rats. This product is for research use only.
- Potent and competitive AMPA/kainate receptor antagonist
- IC50s of 0.3 μM for AMPA and 1.5 μM for kainate receptors
- Competitive non-NMDA receptor antagonist
- Blocks expression of fear-potentiated startle in rats
- Purity of 99.38%
- Appears as a white to yellow solid
- Soluble in DMSO at 20 mg/mL
Medchemexpress LLC NBQX disodium | 479347-86-9 | C12H6N4Na2O6S | 5 MG
NBQX disodium is a highly selective and competitive AMPA receptor antagonist. It exhibits neuroprotective and anticonvulsant activity by targeting AMPA and kainate binding sites, with minimal affinity for the glutamate recognition site on the NMDA receptor complex. It has demonstrated efficacy in decreasing PTZ-induced seizures and neuroprotection in focal ischemia models.
- Highly selective and competitive AMPA receptor antagonist
- Exhibits neuroprotective activity
- Shows anticonvulsant activity
- High affinity for AMPA and kainate binding sites
- Minimal affinity for the glutamate recognition site on the NMDA receptor complex
- Decreases seizures induced by PTZ
- Neuroprotective in focal ischemia models
![eMolecules 1907-33-1 | Lithium tert-butoxide | Oakwood Chemical | MFCD00050479 | 80.060 | C4H9LiO | 0.000 | [Li+].CC(C)(C)[O-] | 100g | 713093105](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000223612.jpg-250.jpg)
eMolecules 1907-33-1 | Lithium tert-butoxide | Oakwood Chemical | MFCD00050479 | 80.060 | C4H9LiO | 0.000 | [Li+].CC(C)(C)[O-] | 100g | 713093105
Lithium tert-butoxide | Oakwood Chemical | 1907-33-1 | MFCD00050479 | 80.060 | C4H9LiO | 0.000 | [Li+].CC(C)(C)[O-] | 100g | 713093105
![eMolecules 2081-12-1 | Zirconium(IV) t-butoxide, 98% | Strem Chemicals | MFCD00075085 | 383.684 | C16H36O4Zr | 98.000 | [Zr+4].CC(C)(C)[O-].CC(C)(C)[O-].CC(C)(C)[O-].CC(C)(C)[O-] | 25g | 321338283](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502168565.JPG-250.jpg)
eMolecules 2081-12-1 | Zirconium(IV) t-butoxide, 98% | Strem Chemicals | MFCD00075085 | 383.684 | C16H36O4Zr | 98.000 | [Zr+4].CC(C)(C)[O-].CC(C)(C)[O-].CC(C)(C)[O-].CC(C)(C)[O-] | 25g | 321338283
Zirconium(IV) t-butoxide, 98% | Strem Chemicals | 2081-12-1 | MFCD00075085 | 383.684 | C16H36O4Zr | 98.000 | [Zr+4].CC(C)(C)[O-].CC(C)(C)[O-].CC(C)(C)[O-].CC(C)(C)[O-] | 25g | 321338283
Medchemexpress LLC Glycerophosphoric acid (disodium salt hydrate) (α and β mixture) | 98.0% | 500 MG
Glycerophosphoric acid (disodium salt hydrate) (α and β mixture) is a complex that contains both alpha and beta glycerophosphoric acid isomers.
- Is a complex mixture of isomers.
- Suitable for biochemical assay applications.
eMolecules 1907-33-1 | Lithium tert-butoxide | Chem-Impex | MFCD00050479 | 80.060 | C4H9LiO | 99.000 | [Li+].CC(C)(C)[O-] | 25g | 809117725
Lithium tert-butoxide | Chem-Impex | 1907-33-1 | MFCD00050479 | 80.060 | C4H9LiO | 99.000 | [Li+].CC(C)(C)[O-] | 25g | 809117725
Medchemexpress LLC Dnqx (FG 9041) | 2379-57-9 | C8H4N4O6 | 10 MM 1 ML
DNQX (FG 9041) is a quinoxaline derivative that functions as a selective, potent competitive non-NMDA glutamate receptor antagonist, demonstrating IC50 values of 0.5, 2, and 40 μM for AMPA, kainate, and NMDA receptors, respectively.
- Selectively depolarizes thalamic reticular nucleus (TRN) neurons in vitro.
- Significantly diminishes phencyclidine (PCP) induced hsp70 in posterior cingulate and retrosplenial cortex in vivo.
Apexbio Technology LLC DIBUTYRYL-CAMP SODI. SALT 50MG
DIBUTYRYL-CAMP SODI. SALT 50MG APEXBIO TECHNOLOGIES
Apexbio Technology LLC CNQX disodium salt 479347-85-8 50mg
CNQX disodium salt (CAS 479347-85-8) is a competitive antagonist of non-NMDA glutamate receptors specifically targeting AMPA and kainate subtypes with IC50 values of 0 3 M and 1 5 M respectively By inhibiting these receptors CNQX blocks fast excitatory synaptic transmission in the central nervous system In thalamic reticular neurons CNQX induces sustained depolarization while showing minimal effect on ventrobasal neurons In vivo administration of CNQX in rats reduces capsaicin-induced c-fos expression in the trigeminal nucleus caudalis without influencing other reticular regions CNQX is widely used to delineate non-NMDA receptor functions in neurophysiological and behavioral studies